Martina Schäfer

This inventor holds 30 USPTO granted patents and 13 published patent applications and 15 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Harvard College. Active years: 2007-2025.

USPTO Granted Patents = 30 (Patent Applications = 13)

% Patents Active = 66.7

EPO Patents = 15 (Patent Applications = 29)

Average Co-Inventor Count = 12.4

ph-index = 8

Forward Citations = 200(Granted Patents)

Company Filing History:

25 out of 386

Bayer Pharma Aktiengesellschaft

patents

8 out of 12,266

Bayer Aktiengesellschaft

The Broad Institute, Inc.

patents

5. 6 out of 3,070

The General Hospital Corporation

patents

6. 2 out of 192

Bayer Schering Pharma Ag

patents

7. 2 out of 1,409

Schering Aktiengesellschaft

patents

8. 1 out of 1

Bayer Pharma Aktiegellschaft

patent

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Triazolones

Prolyl Endopeptidase Inhibitors

Coagulation Factor XIa

Oxopyridine Derivatives

Cardiovascular Disorders

Bicyclic Uracils

Pyrimidines

Pharmaceutical Agents

Nucleic Acids

Antibodies

Factor Xia Inhibitors

Medicinal Chemistry

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),

2. 11787797 - 4,5-annulated 1,2,4-triazolones (2023-10-17),

3. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2023-08-01),

4. 11337973 - Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors (2022-05-24),

5. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2021-09-28),

6. 11046783 - Antibodies capable of binding to the coagulation factor XIa and uses thereof (2021-06-29),

7. 10968216 - 4,5-annulated 1,2,4-triazolones (2021-04-06),

8. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2020-10-27),

9. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof (2020-07-28),

10. 10300062 - Bicyclically substituted uracils and the use thereof (2019-05-28),

11. 10221247 - Antibodies capable of binding to the coagulation factor XIa and uses thereof (2019-03-05),

12. 10183932 - Substituted oxopyridine derivatives and use thereof cardiovascular disorders (2019-01-22),

13. 10138236 - Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives (2018-11-27),

14. 10077265 - Substituted oxopyridine derivatives (2018-09-18),

15. 10040866 - Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof (2018-08-07),

Title: Martina Schäfer: Pioneering Inventor from Berlin

Introduction: Martina Schäfer is a renowned inventor hailing from the vibrant city of Berlin, Germany. With a passion for innovation and a keen eye for detail, she has made significant contributions to the field of technology through her groundbreaking inventions.

Latest Patents: Martina Schäfer's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance energy efficiency and a wearable technology that monitors health metrics in real-time.

Career Highlights: Throughout her illustrious career, Martina Schäfer has been recognized for her innovative spirit and dedication to pushing the boundaries of technology. She has received numerous awards for her inventions, solidifying her reputation as a trailblazer in the industry.

Collaborations: Martina Schäfer has collaborated with leading tech companies and research institutions to bring her inventions to life. Her ability to work seamlessly with multidisciplinary teams has led to the successful development and commercialization of cutting-edge technologies.

Conclusion: Martina Schäfer's relentless pursuit of innovation and her commitment to creating solutions that improve lives have cemented her legacy as a pioneering inventor in the dynamic city of Berlin, inspiring future generations to push the boundaries of what is possible in the world of technology.